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Background: Atrial fibrillation (AF), the most common arrhythmia in the general population, is as-
sociated with accelerated cognitive decline in comparison with healthy individuals1. Some studies 
reported that the duration of exposure to AF increases the risk of dementia2. Objective: The aim of this 
study was to evaluate the reported link between AF and its characteristics, such as type and duration, 
and cognitive abilities in affected individuals. 
Patients and Methods: 105 patients (63 males, 42 females, aged 67.29±24.54 years) from the Univer-
sity Hospital Centre Zagreb outpatient department were enrolled in the study. The average duration of 
paroxysmal AF was 46.52, and of persistent AF 87.94 Mo. The patients’ cognitive abilities were evalu-
ated using Mini Mental State Examination (MMSE). Other confounding factors were analyzed: body 
mass index, comorbidities (hypertension, diabetes, hyperlipidemia, ischemic heart disease, etc.), level 
of education, prescribed medications, blood biochemistry, and echocardiographic parameters. 
Results: No significant differences between MMSE scores of patients with paroxysmal and persistent 
AF were found (27.43 in those with paroxysmal and 27.09 in those with persistent AF, p=0.5698). Sta-
tistical analysis also showed no correlation between the duration of AF and MMSE results (r=-0.0805, 
p=0.451), which was in contrast with predicted findings. However, we found a statistically significant 
difference between MMSE scores of patients grouped by their achieved level of education (24.60, 27.70, 
28.25 and 28.22 in patients with primary, secondary, post-secondary and tertiary level of education, 
respectively, p=0.00002), and a correlation with estimated glomerular filtration rate (r=0.199, p<0.05) 
and heart rate (r=-0.2291, p=0.026). Female participants had lower MMSE scores than males (26.31 in 
females and 27.89 in males, p=0.038) and participants’ age also affected their MMSE results (r=-0.2866, 
p=0.003). 
Conclusion: The results of this pilot study do not support previously described correlations between 
the duration and type of AF and cognitive deterioration, at least not measurable by MMSE. Our results 
indicated that the strongest predictor of one’s MMSE score is the achieved level of education. This re-
search will be continued, and we expect more reliable results on a larger cohort of patients. 
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